Mustang Bio Company
Mustang Bio is a clinical-stage biopharmaceutical company .
.png)
Total Funding:
204300000
Last Funding Type:
Post-IPO Debt
Estimated Revenue:
$10M to $50M
Founded Date:
2015-01-01
Industry:
CAR-T
Last Funding Date:
2022-03-08
Funding Status:
IPO
Headquarters:
New York, New York, United States
Investors Number:
4